2 assets in Candidiasis, Invasive

Therapeutic assets addressing Candidiasis, Invasive, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Fluconazole Candidiasis, Invasive	Radboud University Medical Center	P4	BB (69)
Posaconazole Candidiasis, Invasive	Bochud Pierre-Yves	N/A	D (30)